Publisher Correction: Leveraging Multi-National Observational Study in Post-Marketing Safety Assessment: Challenges and Strategies...Lin LA, Hammad TA, Liu W et al. Therapeutic Innovation & Regulatory Science, 2025; 59(6): 1526-1536.
| Publicado en: | Therapeutic Innovation & Regulatory Science Vol. 59; no. 6; pp. 1537 - 1538 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | corrected article Journal Article |
| Publicado: |
Springer Nature
Nov2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189054780&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 189054780 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 21684790 FUHO jtl: Therapeutic Innovation & Regulatory Science issn: 21684790 maglogo: N pubinfo: dt: Nov2025 vid: 59 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 189054780 189054780 189054780 10.1007/s43441-025-00858-z 189054780 ppf: 1537 ppct: 1 formats: tig: atl: Publisher Correction: Leveraging Multi-National Observational Study in Post-Marketing Safety Assessment: Challenges and Strategies...Lin LA, Hammad TA, Liu W et al. Therapeutic Innovation & Regulatory Science, 2025; 59(6): 1526-1536. aug: au: Lin, Li-An Hammad, Tarek A Liu, Wei Ma, Yong Whalen, Ed Sinvhal, Ranjeeta Munsaka, Melvin Wang, William affil: https://ror.org/01xm4wg91 Safety Statistics, Moderna Inc, Cambridge, MA, USA sug: subj: Marketing Patient Safety Product Surveillance Adverse Drug Event Prevention and Control pubtype: Academic Journal doctype: corrected article Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|